Submitted:
31 May 2025
Posted:
03 June 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Sample collection and nucleic acids extraction
2.2. qPCR for PCV2 and PCV3 detection
2.3. Conventional PCR amplification of positive qPCR samples
2.4. Sanger sequencing
2.5. Phylogenetic analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| MDPI | Multidisciplinary Digital Publishing Institute |
| DOAJ | Directory of open access journals |
| TLA | Three letter acronym |
| LD | Linear dichroism |
| °C | Degrees Celsius |
| µL | Microliter |
| µM | Micromolar |
| bp | Base pairs |
| Ct | Cycle threshold |
| F | Forward |
| FAM | 6-carboxyfluorescein |
| HEV | Hepatitis E virus |
| HSD | Honestly Significant Difference |
| PBS | Phosphate-buffered saline |
| PCR | Polymerase Chain Reaction |
| PCV2 | Porcine Circovirus type 2 |
| PCV3 | Porcine Circovirus type 3 |
| PCV4 | Porcine Circovirus type 4 |
| PCVAD | Porcine circovirus-associated diseases |
| qPCR | Quantitative Polymerase Chain Reaction |
| R | Reverse |
| w/v | Weight per volume |
| ×g | Relative Centrifugal Force (RCF) |
References
- Segalés, J. Porcine Circovirus Type 2 (PCV2) Infections: Clinical Signs, Pathology and Laboratory Diagnosis. Virus Res. 2012, 164, 10–19. [Google Scholar] [CrossRef] [PubMed]
- Faccini, S.; Barbieri, I.; Gilioli, A.; Sala, G.; Gibelli, L.R.; Moreno, A.; Sacchi, C.; Rosignoli, C.; Franzini, G.; Nigrelli, A. Detection and Genetic Characterization of Porcine Circovirus Type 3 in Italy. Transbound. Emerg. Dis. 2017, 64, 1661–1664. [Google Scholar] [CrossRef] [PubMed]
- Czyżewska-Dors, E.; Núñez, J.I.; Saporiti, V.; Huerta, E.; Riutord, C.; Cabezón, O.; Segalés, J.; Sibila, M. Detection of Porcine Circovirus 3 in Wildlife Species in Spain. Pathogens 2020, 9, 341. [Google Scholar] [CrossRef] [PubMed]
- Stadejek, T.; Woźniak, A.; Miłek, D.; Biernacka, K. First Detection of Porcine Circovirus Type 3 on Commercial Pig Farms in Poland. Transbound. Emerg. Dis. 2017, 64, 1350–1353. [Google Scholar] [CrossRef] [PubMed]
- Almeida, B.; Marçal, S.; Duarte, M.D.; Duarte, A.; Fagulha, T.; Ramos, F.; Barros, S.C.; Luís, T.; Henriques, A.M. Molecular Detection of Porcine Circovirus Type 2 and 3 in Pig Farms: First Report of PCV3 in Portugal. Curr. Top. Virol. 2023. [Google Scholar]
- Klaumann, F.; Correa-Fiz, F.; Giovanni, F.; Sibila, M.; Núñez, J.I.; Segalés, J. Current Knowledge on Porcine circovirus 3 (PCV-3): A Novel Virus With a Yet Unknown Impact on the Swine Industry. [CrossRef]
- Fernandes, L.M. da C.G.R. Avaliação de um programa de vacinação de circovirose suína numa exploração de produção intensiva. Master thesis, Universidade de Lisboa, Faculdade de Medicina Veterinária, 2017.
- Henriques, A.M.; Duarte, M.; Fagulha, T.; Ramos, F.; Barros, S.C.; Luís, T.; Fevereiro, M. Molecular study of porcine circovirus type 2 circulating in Portugal. [CrossRef]
- Meng, X.J.; Lindsay, D.S.; Sriranganathan, N. Wild Boars as Sources for Infectious Diseases in Livestock and Humans. Philos. Trans. R. Soc. B Biol. Sci. 2009, 364, 2697–2707. [Google Scholar] [CrossRef] [PubMed]
- Gillespie, J.; Opriessnig, T.; Meng, X.J.; Pelzer, K.; Buechner-Maxwell, V. Porcine Circovirus Type 2 and Porcine Circovirus-Associated Disease. J. Vet. Intern. Med. 2009, 23, 1151–1163. [Google Scholar] [CrossRef] [PubMed]
- Dei Giudici, S.; Franzoni, G.; Bonelli, P.; Angioi, P.P.; Zinellu, S.; Deriu, V.; Carta, T.; Sechi, A.M.; Salis, F.; Balzano, F.; et al. Genetic Characterization of Porcine Circovirus 3 Strains Circulating in Sardinian Pigs and Wild Boars. Pathogens 2020, 9, 344. [Google Scholar] [CrossRef] [PubMed]
- Prinz, C.; Stillfried, M.; Neubert, L.K.; Denner, J. Detection of PCV3 in German Wild Boars. Virol. J. 2019, 16, 25. [Google Scholar] [CrossRef] [PubMed]




| Reaction | Name | Sequence |
|---|---|---|
| qPCR PCV2 | PCV2-PT-rep6(F) | 5’ - CAG CAA GAA GAA TGG AAG - 3' |
| PCV2-PT-rep149(R) | 5' - TTA CCC TCC TCG CCA AC - 3' | |
| PCV2-PT probe(R) | 5’ - [FAM]TCC CGT ATT TTC TTG CGC TCG TCT TC - 3 | |
| qPCR PCV3 | PCV3_real_FW | 5’ - AGT GCT CCC CAT TGA ACG - 3' |
| PCV3_real_RV | 5' - ACA CAG CCG TTA CTT CAC - 3' | |
| PCV3_real_probe | 5’ - [FAM]ACC CCA TGG CTC AAC ACA TAT GAC C - 3' | |
| PCR PCV2 | S4 | 5' – CAC GGA TAT TGT AGT CCT GGT - 3' |
| AS4 | 5' - CCG CAC CTT CGG ATA TAC TGT C - 3' | |
| PCR PCV3 | PCV3_seq2_FW | 5' - GTC GTC TTG GAG CCA AGT G - 3' |
| PCV3_seq2_RV | 5’ - CGA CCA AAT CCG GGT AAG C - 3' |
| Group | Epidemiological unit | Year of sampling | Age | Number of tested animals | PCV2 infection |
PCV3 infection |
PCV2 and PCV3 coinfection |
|---|---|---|---|---|---|---|---|
| Domestic pig | Quarantine | 2024 | Any | 5 | 0 | 1 (20.0%) | 0 |
| Nursery | 3 to 10 weeks | 24 | 1 (4.2%) | 3 (12.5%) | 1 (4.2%) | ||
| Fattening | 10 weeks to 6 months | 28 | 2 (7.1%) | 3 (10.7%) | 0 | ||
| Breeding Stalls | More than 7 months | 21 | 0 | 1 (4.8%) | 0 | ||
| Gestation | More than 7 months | 44 | 0 | 3 (6.8%) | 0 | ||
| Maternity | More than 8 months | 38 | 0 | 7 (18.4%) | 0 | ||
| Total Pig | - | 160 | 3 (1.9%) | 18 (11.2%) | 1 (0.6%) | ||
| Wild Boar | N/A | 2023 | Unknown | 30 | 28 (93.3%) | 20 (66.7%) | 19 (63.3%) |
| 2024 | Unknown | 89 | 64 (71.2%) | 46 (51.7%) | 33 (37.1%) | ||
| 2025 | Unknown | 1 | 0 | 0 | 0 | ||
| Total Wild Boar | - | 120 | 92 (76.7%) | 66 (55.0%) | 52 (43.3%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).